Peptides for treating Sjogren's syndrome
US11167005B2 · kind B2 · utility
0Cited by
2References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 4, 2018 |
| Grant date | Nov 9, 2021 |
| Priority date | — |
| Expiry date | Jan 4, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for the treatment of Sjogren's syndrome (SS) and SS-related symptoms in human subjects are described. The compositions comprise synthetic peptides based on the sequence of CDR1 of an anti-DNA monoclonal antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.